查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2003556

全球光療市場：按光源、產品、終端用戶和應用進行分析—市場規模、產業動態、機會分析和預測（2026-2035 年）

Global Light Therapy Market: Analysis By Light Type, Product, End User, Application -Market Size, Industry Dynamics, Opportunity Analysis and Forecast for 2026-2035
出版日期: | 出版商: Astute Analytica | 英文 240 Pages | 商品交期: 最快1-2個工作天內

價格
簡介目錄

全球光療市場正經歷穩定持續成長，反映出其作為有效治療方法在醫療保健和健康領域的重要性日益凸顯。預計到2025年，全球光療市場規模將達到11.7422億美元，並在未來十年內顯著擴張，2035年將達到約19.4203億美元。這一成長意味著2026年至2035年預測期間的複合年成長率（CAGR）為5.16%，顯示全球對光療技術的接受度和應用率正在不斷提高。

推動這一上升趨勢的主要因素有幾個。其中一個主要成長動力是非侵入性和無藥物治療方法的日益普及，這得益於患者尋求更安全、更天然的傳統藥物療法替代方案。光療在治療憂鬱症和季節性情感障礙等精神疾病以及痤瘡和乾癬等各種皮膚疾病方面尤其受到關注。此外，光療在疼痛管理方面的效用也日益受到認可，因為它可以在不增加長期用藥風險的情況下緩解疼痛症狀。

顯著的市場趨勢

在光療市場，Signify（飛利浦）、Buehler 和 Drager 等一級企業脫穎而出，成為市場領導者。這些公司憑藉其豐富的經驗和良好的聲譽，贏得了利潤盈利的醫院契約，並維持著強大的全球分銷網路。它們以創新和可靠性為基石，在臨床環境中建立了值得信賴的光療解決方案供應商形象。

同時，Joovv、Celluma 和 PlatinumLED 等二線公司被視為產業顛覆者，主要目標市場是「專業消費者」和家庭市場。這些數位原生品牌採用網紅行銷和直銷等創新行銷策略，有效繞過傳統醫療通路，直接接觸消費者。透過利用社交媒體平台和線上社區，這些公司建立了忠實的基本客群，這些客戶重視個人光療產品的便利性和易用性。

這些層級之間的競爭動態凸顯了光療市場格局的演變。一級企業繼續主導機構銷售，並與醫療服務提供者保持牢固的合作關係，而二級顛覆者則正在重新定義消費者使用和獲取光療解決方案的方式。這種市場兩極化不僅推動了創新，也促使企業開發更廣泛的產品系列，以滿足專業和家庭應用的需求。

主要成長促進因素

持續的精神健康危機，尤其是在2020年以來發生的一系列事件的加劇下，已成為光療市場（特別是非藥物光療領域）成長的重要驅動力。重度憂鬱症（MDD）和季節性情緒障礙（SAD）病例的激增，導致精神科治療需求與現有精神健康服務供給之間出現嚴重失衡。這場危機促使患者和醫療服務提供者尋求不完全依賴傳統藥物療法的替代治療方法。

新機會的趨勢

隨著OLED貼片的問世，光療的未來即將迎來重大變革。最尖端科技可望重新定義光生物調節（PBM）的治療方式。與傳統治療方法需要患者長時間坐在笨重的面板前不同，OLED貼片提供了一種靈活、穿戴式的解決方案，可以直接貼在皮膚上。這些貼片旨在全天持續釋放低劑量光療能量，使治療更無縫地融入患者的日常生活。這項創新有望顯著提升光療的便利性和可近性，使用戶更容易堅持治療方案。

最佳化障礙

光療市場面臨的日益嚴峻的威脅之一是高功率、無防護措施的LED設備的快速普及，這些設備對消費者構成重大安全風險。這些設備，特別是那些發射波長在415奈米附近的高輻照度藍光和近紅外光（NIR）的設備，如果直接照射到使用者的眼睛，被認為可能對視網膜造成光化學損傷。隨著越來越多的消費者在缺乏適當指導或防護措施的情況下使用這些高功率設備，人們對這些風險的關注度正在不斷提高，對不當使用危害的認知也不斷增強。

目錄

第1章執行摘要：全球光療市場

第2章：報告概述

  • 研究框架
    • 研究目標
    • 市場的定義
    • 市場區隔
  • 調查方法
    • 市場規模估算
    • 定性研究
    • 量化研究
    • 初步調查受訪者組成：依地區分類
    • 數據檢驗
    • 研究的先決條件

第3章：全球光療市場概覽

  • 產業價值鏈分析
    • 原物料供應商
    • LED模組和裝置製造商
    • 醫療和保健設備組裝公司
    • 分銷管道
    • 最終用戶
  • 產業展望
    • 對活膚日益成長的需求
    • 家用照光治療設備的廣泛應用
    • 擴大在疼痛和發炎治療的應用
  • PESTLE分析
  • 波特五力分析
    • 供應商的議價能力
    • 買方的議價能力
    • 替代品的威脅
    • 新進入者的威脅
    • 競爭強度
  • 市場成長及前景
    • 市場收入估算與預測（2020-2035 年）
  • 市場吸引力分析
    • 依產品類型
  • 可執行的見解（分析師建議）

第4章：競爭對手儀錶板

  • 市場集中度
  • 企業市場占有率分析
  • 競爭對手分析與基準測試

第5章：全球光療市場分析

  • 市場動態和趨勢
    • 成長促進因素
    • 抑制因子
    • 機會
    • 主要趨勢
  • 市場規模及預測（2020-2035）
    • 依產品
    • 透過使用
    • 透過光源
    • 最終用戶
    • 按地區

第6章：北美光療市場分析

第7章：歐洲光療市場分析

第8章：亞太光療市場分析

第9章：中東和非洲光療市場分析

第10章：南美光療市場分析

第11章：公司簡介（公司概況、歷史沿革、組織架構、主要產品組合、財務指標、主要客戶/產業、主要競爭對手、SWOT 分析、聯絡方式和業務策略展望）

  • 全球公司
    • Beurer
    • BioPhotas
    • Daylight Company
    • Koninklijke Philips
    • Lumie
    • Naturebright
    • Northern Light Technologies
    • Verilux
    • Zepter International
    • Zerigo Health
    • 其他主要企業

第12章附錄

簡介目錄
Product Code: AA02261717

The global light therapy market is witnessing steady and sustained growth, reflecting its rising prominence as an effective treatment modality across various medical and wellness applications. Valued at USD 1,174.22 million in 2025, the market is projected to expand significantly over the next decade, reaching a valuation of approximately USD 1,942.03 million by 2035. This growth corresponds to a compound annual growth rate (CAGR) of 5.16% during the forecast period from 2026 to 2035, underscoring the increasing acceptance and integration of light therapy technologies worldwide.

Several key factors are driving this upward trajectory. One of the primary growth engines is the rising adoption of non-invasive and drug-free treatment options, which appeal to patients seeking safer and more natural alternatives to conventional pharmaceutical therapies. Light therapy has gained particular traction in managing mental health conditions such as depression and seasonal affective disorder, as well as in treating various skin disorders like acne and psoriasis. Additionally, its utility in pain management is becoming increasingly recognized, offering relief without the risks associated with long-term medication use.

Noteworthy Market Developments

In the light therapy market, Tier 1 companies, such as Signify (Philips), Beurer, and Draeger, stand out as market leaders, leveraging their extensive experience and established reputations to secure lucrative hospital contracts and maintain robust global distribution networks. These firms have built their success on a foundation of innovation and reliability, positioning themselves as trusted providers of light therapy solutions in clinical settings.

On the other hand, Tier 2 companies, including Joovv, Celluma, and PlatinumLED, are characterized as disruptors in the industry, primarily targeting the "prosumer" and home-use markets. These digital-native brands have adopted innovative marketing strategies, using influencer marketing and direct sales approaches to reach consumers directly, effectively bypassing traditional medical distribution channels. By leveraging social media platforms and online communities, these companies have successfully cultivated a loyal customer base that values the convenience and accessibility of light therapy products for personal use.

The competitive dynamics between these tiers highlight the evolving landscape of the light therapy market. While Tier 1 companies continue to dominate institutional sales and maintain strong relationships with healthcare providers, Tier 2 disruptors are redefining consumer engagement and access to light therapy solutions. This duality in the market not only fosters innovation but also encourages a broader range of product offerings, catering to both professional and home-use applications.

Core Growth Drivers

The ongoing mental health crisis, particularly exacerbated by the events following 2020, is a significant factor propelling growth in the light therapy market, especially in relation to non-pharmacological interventions. The surge in cases of Major Depressive Disorder (MDD) and Seasonal Affective Disorder (SAD) has resulted in a notable imbalance between the demand for psychiatric care and the available supply of mental health services. This crisis has prompted both patients and healthcare providers to seek alternative treatment options that do not rely solely on traditional pharmacological approaches.

Emerging Opportunity Trends

The future of light therapy is poised to be transformed by the emergence of OLED patches, a cutting-edge technology that promises to redefine how photobiomodulation (PBM) is delivered. Unlike traditional treatments that require patients to sit in front of bulky panels for fixed periods, OLED patches offer a flexible, wearable solution that adheres directly to the skin. These patches are designed to deliver low-dose, continuous light therapy throughout the day, allowing for a more seamless integration of treatment into patients' daily lives. This innovation has the potential to greatly enhance the convenience and accessibility of light therapy, making it easier for users to maintain consistent treatment regimens.

Barriers to Optimization

A growing concern threatening the light therapy market is the rapid proliferation of high-powered, unshielded LED devices, which pose significant safety risks to consumers. These devices, particularly those emitting high-irradiance blue light at around 415nm and near-infrared (NIR) light, have been linked to potential retinal photochemical injury when users are exposed directly to the eyes. Such risks are increasingly coming under scrutiny as more consumers adopt these powerful devices without proper guidance or protective measures, leading to heightened awareness about the dangers of improper use.

Detailed Market Segmentation

By Product, the handheld devices segment captured the largest market share within the light therapy market, reflecting a significant shift in how consumers access and engage with dermatological treatments. This growth is largely driven by the aggressive "consumerization" of clinical dermatology, which has made advanced skincare technologies more accessible and user-friendly for everyday consumers. Unlike bulky full-body panels or stationary light therapy stands that require dedicated space and longer treatment times, handheld devices-such as wands, combs, and spot-treatment units-offer portability, convenience, and targeted application.

By Application, the sleep disorder segment garnered substantial revenue within the light therapy market, reflecting a significant shift in consumer health priorities and medical understanding. This growth has been fundamentally driven by the global post-pandemic surge in insomnia cases, which highlighted the widespread impact of disrupted sleep patterns on mental and physical well-being. The pandemic's effects on daily routines, stress levels, and social interactions have contributed to a rise in sleep-related issues, prompting increased demand for effective, non-pharmaceutical treatments such as light therapy.

By End-Use, by 2026, the Home Healthcare segment has solidified its leading position in the light therapy market, marking a significant structural shift in how photomedicine is delivered and accessed. This transformation reflects a broader trend toward decentralizing healthcare from clinical settings to patients' homes, allowing individuals to take a more active role in managing their health and wellness. The convenience and accessibility of home-based light therapy devices have greatly expanded the market, making effective treatments available to a wider audience without the need for frequent clinical visits.

By Light Type, in the rapidly maturing light therapy market of 2026, the Red Light spectrum, which ranges from 600nm to 700nm, has firmly established itself as the leading segment in terms of revenue generation. This specific wavelength range has gained widespread recognition for its therapeutic benefits, driving strong demand across various medical and wellness applications. As a result, it now accounts for over 36% of the total market share, making it the most significant contributor to the industry's growth.

Segment Breakdown

By Product

  • Light Box
  • Floor and Desk Lamps
  • Handheld Devices
  • Light Visor
  • Dawn Simulator
  • Light Therapy Lamps

By Application

  • Psoriasis
  • Vitiligo
  • Eczema
  • Acne Vulgaris
  • SAD/Winter Blues
  • Sleeping Disorders

By Light Type

  • Blue Light
  • Red Light
  • White Light

By End User

  • Dermatology Clinics
  • Home Healthcare

By Region

  • North America
  • The U.S.
  • Canada
  • Mexico
  • Europe
  • Western Europe
  • The UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Western Europe
  • Eastern Europe
  • Poland
  • Russia
  • Rest of Eastern Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia & New Zealand
  • South Korea
  • ASEAN
  • Rest of Asia Pacific
  • Middle East & Africa (MEA)
  • Saudi Arabia
  • South Africa
  • UAE
  • Rest of MEA
  • South America
  • Argentina
  • Brazil
  • Rest of South America

Geography Breakdown

  • North America holds a commanding 38% share of the global light therapy market, reflecting the region's advanced healthcare infrastructure and strong focus on innovation. This significant market presence is partly driven by the relatively high prevalence of psoriasis, affecting approximately 3% of the population, which has spurred demand for effective treatment options. The region's healthcare providers and consumers have rapidly embraced FDA-cleared LED-based phototherapy devices, which offer safe and efficient treatment alternatives.
  • In the United States, companies are at the forefront of developing AI-driven personalization features that enhance treatment efficacy and user experience. For example, VitalLight has pioneered app-controlled dosing systems, allowing patients to customize their phototherapy regimens with greater precision and convenience. Additionally, the U.S. market is witnessing the rise of combination therapies that merge traditional phototherapy with biologic drugs, providing improved outcomes for patients with chronic skin conditions.
  • The robust investment landscape further fuels growth in the region. In 2025 alone, venture capital firms invested approximately $280 million in photomedtech startups, signaling strong confidence in the sector's potential. This influx of funding supports research, product development, and market expansion, driving continuous improvements in light therapy technology. Beyond the United States, Canada contributes to the market by focusing on niche applications such as treating seasonal affective disorder (SAD) and eczema, particularly among the geriatric population. These specialized uses highlight the versatility of light therapy across different demographic groups and medical needs.

Leading Market Participants

  • Beurer
  • BioPhotas
  • Daylight Company
  • Koninklijke Philips
  • Lumie
  • Naturebright
  • Northern Light Technologies
  • Verilux
  • Zepter International
  • Zerigo Health
  • Other Prominent Players

Table of Content

Chapter 1. Executive Summary: Global Light Therapy Market

Chapter 2. Report Description

  • 2.1. Research Framework
    • 2.1.1. Research Objective
    • 2.1.2. Market Definitions
    • 2.1.3. Market Segmentation
  • 2.2. Research Methodology
    • 2.2.1. Market Size Estimation
    • 2.2.2. Qualitative Research
      • 2.2.2.1. Primary & Secondary Sources
    • 2.2.3. Quantitative Research
      • 2.2.3.1. Primary & Secondary Sources
    • 2.2.4. Breakdown of Primary Research Respondents, By Region
    • 2.2.5. Data Triangulation
    • 2.2.6. Assumption for Study

Chapter 3. Global Light Therapy Market Overview

  • 3.1. Industry Value Chain Analysis
    • 3.1.1. Raw Material Suppliers
    • 3.1.2. LED Module & Device Manufacturers
    • 3.1.3. Medical & Wellness Device Assemblers
    • 3.1.4. Distribution Channel
    • 3.1.5. End User
  • 3.2. Industry Outlook
    • 3.2.1. Rising demand for skin rejuvenation
    • 3.2.2. Expansion of home-use light therapy devices
    • 3.2.3. Increasing adoption in pain & inflammation therapy
  • 3.3. PESTLE Analysis
  • 3.4. Porter's Five Forces Analysis
    • 3.4.1. Bargaining Power of Suppliers
    • 3.4.2. Bargaining Power of Buyers
    • 3.4.3. Threat of Substitutes
    • 3.4.4. Threat of New Entrants
    • 3.4.5. Degree of Competition
  • 3.5. Market Growth and Outlook
    • 3.5.1. Market Revenue Estimates and Forecast (US$ Mn), 2020-2035
  • 3.6. Market Attractiveness Analysis
    • 3.6.1. By Product Type
  • 3.7. Actionable Insights (Analyst's Recommendations)

Chapter 4. Competition Dashboard

  • 4.1. Market Concentration Rate
  • 4.2. Company Market Share Analysis (Value %), 2025
  • 4.3. Competitor Mapping & Benchmarking

Chapter 5. Global Light Therapy Market Analysis

  • 5.1. Market Dynamics and Trends
    • 5.1.1. Growth Drivers
      • 5.1.1.1. Growing demand for non-invasive, drug-free treatment solutions is being driven
    • 5.1.2. Restraints
    • 5.1.3. Opportunity
    • 5.1.4. Key Trends
  • 5.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 5.2.1. By Product
      • 5.2.1.1. Key Insights
        • 5.2.1.1.1. Light Box
        • 5.2.1.1.2. Floor and Desk Lamps
        • 5.2.1.1.3. Handheld Devices
        • 5.2.1.1.4. Light Visor
        • 5.2.1.1.5. Dawn Simulator
        • 5.2.1.1.6. Light Therapy Lamps
    • 5.2.2. By Application
      • 5.2.2.1. Key Insights
        • 5.2.2.1.1. Psoriasis
        • 5.2.2.1.2. Vitiligo
        • 5.2.2.1.3. Eczema
        • 5.2.2.1.4. Acne Vulgaris
        • 5.2.2.1.5. SAD/Winter Blues
        • 5.2.2.1.6. Sleeping Disorders
    • 5.2.3. By Light Type
      • 5.2.3.1. Key Insights
        • 5.2.3.1.1. Blue Light
        • 5.2.3.1.2. Red Light
        • 5.2.3.1.3. White Light
    • 5.2.4. By End User
      • 5.2.4.1. Key Insights
        • 5.2.4.1.1. Dermatology Clinics
        • 5.2.4.1.2. Home Healthcare
    • 5.2.5. By Region
      • 5.2.5.1. Key Insights
        • 5.2.5.1.1. North America
          • 5.2.5.1.1.1. The U.S.
          • 5.2.5.1.1.2. Canada
          • 5.2.5.1.1.3. Mexico
        • 5.2.5.1.2. Europe
          • 5.2.5.1.2.1. Western Europe
            • 5.2.5.1.2.1.1. The UK
            • 5.2.5.1.2.1.2. Germany
            • 5.2.5.1.2.1.3. France
            • 5.2.5.1.2.1.4. Italy
            • 5.2.5.1.2.1.5. Spain
            • 5.2.5.1.2.1.6. Rest of Western Europe
          • 5.2.5.1.2.2. Eastern Europe
            • 5.2.5.1.2.2.1. Poland
            • 5.2.5.1.2.2.2. Russia
            • 5.2.5.1.2.2.3. Rest of Eastern Europe
        • 5.2.5.1.3. Asia Pacific
          • 5.2.5.1.3.1. China
          • 5.2.5.1.3.2. India
          • 5.2.5.1.3.3. Japan
          • 5.2.5.1.3.4. South Korea
          • 5.2.5.1.3.5. Australia & New Zealand
          • 5.2.5.1.3.6. ASEAN
          • 5.2.5.1.3.7. Rest of Asia Pacific
        • 5.2.5.1.4. Middle East & Africa
          • 5.2.5.1.4.1. UAE
          • 5.2.5.1.4.2. Saudi Arabia
          • 5.2.5.1.4.3. South Africa
          • 5.2.5.1.4.4. Rest of MEA
        • 5.2.5.1.5. South America
          • 5.2.5.1.5.1. Argentina
          • 5.2.5.1.5.2. Brazil
          • 5.2.5.1.5.3. Rest of South America

Chapter 6. North America Light Therapy Market Analysis

  • 6.1. Market Dynamics and Trends
    • 6.1.1. Growth Drivers
    • 6.1.2. Restraints
    • 6.1.3. Opportunity
    • 6.1.4. Key Trends
  • 6.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 6.2.1. By Product
    • 6.2.2. By Application
    • 6.2.3. By Light Type
    • 6.2.4. By End-User
    • 6.2.5. By Country

Chapter 7. Europe Light Therapy Market Analysis

  • 7.1. Market Dynamics and Trends
    • 7.1.1. Growth Drivers
    • 7.1.2. Restraints
    • 7.1.3. Opportunity
    • 7.1.4. Key Trends
  • 7.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 7.2.1. By Product
    • 7.2.2. By Application
    • 7.2.3. By Light Type
    • 7.2.4. By End-User
    • 7.2.5. By Country

Chapter 8. Asia Pacific Light Therapy Market Analysis

  • 8.1. Market Dynamics and Trends
    • 8.1.1. Growth Drivers
    • 8.1.2. Restraints
    • 8.1.3. Opportunity
    • 8.1.4. Key Trends
  • 8.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 8.2.1. By Product
    • 8.2.2. By Application
    • 8.2.3. By Light Type
    • 8.2.4. By End-User
    • 8.2.5. By Country

Chapter 9. Middle East & Africa Light Therapy Market Analysis

  • 9.1. Market Dynamics and Trends
    • 9.1.1. Growth Drivers
    • 9.1.2. Restraints
    • 9.1.3. Opportunity
    • 9.1.4. Key Trends
  • 9.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 9.2.1. By Product
    • 9.2.2. By Application
    • 9.2.3. By Light Type
    • 9.2.4. By End-User
    • 9.2.5. By Country

Chapter 10. South America Light Therapy Market Analysis

  • 10.1. Market Dynamics and Trends
    • 10.1.1. Growth Drivers
    • 10.1.2. Restraints
    • 10.1.3. Opportunity
    • 10.1.4. Key Trends
  • 10.2. Market Size and Forecast, 2020-2035 (US$ Mn)
    • 10.2.1. By Product
    • 10.2.2. By Application
    • 10.2.3. By Light Type
    • 10.2.4. By End-User
    • 10.2.5. By Country

Chapter 11. Company Profile (Company Overview, Company Timeline, Organization Structure, Key Product landscape, Financial Matrix, Key Customers/Sectors, Key Competitors, SWOT Analysis, Contact Address, and Business Strategy Outlook)

  • 11.1. Global Players
    • 11.1.1. Beurer
    • 11.1.2. BioPhotas
    • 11.1.3. Daylight Company
    • 11.1.4. Koninklijke Philips
    • 11.1.5. Lumie
    • 11.1.6. Naturebright
    • 11.1.7. Northern Light Technologies
    • 11.1.8. Verilux
    • 11.1.9. Zepter International
    • 11.1.10. Zerigo Health
    • 11.1.11. Other Prominent Players

Chapter 12. Annexure

  • 13.1 List of Secondary Sources
  • 13.2 Key Country Markets- Macro Economic Outlook/Indicators